Drug
Tablets clinical trials
Includes 1 study of Sustained Release Tablet Dosage Form.
- studies test it
- 13
- open now
- 0
- in phase 3
- 1
- first study started
- 2003
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
13 studies that test it; most in 2003 (2)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 3
- 1
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 2
Teva Pharmaceuticals USA (2) · Ranbaxy Laboratories Limited (2) · Fraunhofer-Institute of Toxicology and Experimental Medicine (1) · Sandoz (1) · ViiV Healthcare (1) · Merck Sharp & Dohme LLC (1) · Abbott (1) · Mexican National Institute of Public Health (1)
Often tested with
Tested in the same studies.
Metformin (3) · Glyburide (2) · Benazepril (2) · Hydrochlorothiazide (2) · Cetirizine (1) · Pseudoephedrine (1) · Dolutegravir (1) · Lamivudine (1)
Studies
Open first, then newest update. How each study uses Tablets is read from its arms, and is right about nine times in ten.
Testing it · 13
- Use of Exhaled Particles to Assess Lung PharmacokineticsCompletedNot applicableFraunhofer-Institute of Toxicology and Experimental MedicineNCT04914273Written as Tablet
- Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, FedCompletedPhase 1Teva Pharmaceuticals USANCT00835991Written as Glyburide/Metformin 5 mg/500 mg Tablets
- Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, FastingCompletedPhase 1Teva Pharmaceuticals USANCT00836472Written as Glyburide/Metformin 5 mg/500 mg Tablets
- A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.TerminatedPhase 1PfizerNCT00857571Written as 150 mg Tablet
- To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed ConditionsCompletedPhase 1SandozNCT00881634Written as Cetirizine HCl/Pseudoephedrine HCl 5 mg/120 mg Tablets (Sandoz, USA)
- Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose CombinationsCompletedPhase 1ViiV HealthcareNCT02738931Written as Dolutegravir/Lamivudine 50 mg/300 mg Tablet (Product Code AA)
- Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)CompletedPhase 1Merck Sharp & Dohme LLCNCT01093794Written as sitagliptin/metformin 50 mg/500 mg tablet
- Study With Heptral in Subjects With Liver Disease Due to Alcohol ConsumptionCompletedPhase 3AbbottNCT02200029Written as Ademetionine IV+tablet
- Efficacy of 3 Nutritional Supplements to Improve Diverse Outcomes in Children Under 2 Years of Age and Pregnant WomenCompletedNot applicableMexican National Institute of Public HealthNCT00531674Written as tablets
- Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release FormulationCompletedPhase 1IlDong Pharmaceutical Co LtdNCT02103647Written as sustained release tablet
- An Open-Label Study of Two Formulations of LX1033 in Healthy Human SubjectsCompletedPhase 1Lexicon PharmaceuticalsNCT01411800Written as 250 mg tablets
- Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed ConditionsCompletedNot applicableRanbaxy Laboratories LimitedNCT00778674Written as Benazepril HCl/ Hydrochlorothiazide 20 mg/ 25 mg Tablets
- Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting ConditionsCompletedNot applicableRanbaxy Laboratories LimitedNCT00778726Written as Benazepril HCl/ Hydrochlorothiazide 20 mg/ 25 mg Tablets